TrialJournal of oral & facial pain and headache2025

A randomized, double blind, placebo-controlled pilot study to assess the efficacy of erenumab in individuals with temporomandibular disorder.

Harold C Avila et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.